BlackRock
HELP

BlackRock’s Helus Pharma Inc. Common Stock HELP Stock Holding History

BlackRock’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$534K Buy
80,719
+51,593
+177% +$258K ﹤0.01% 4563
2026
Q1 		$140K Buy
29,126
+3,723
+15% +$24.1K ﹤0.01% 4881
2025
Q4 		$208K Sell
25,403
-115,917
-82% -$746K ﹤0.01% 4715
2025
Q3 		$832K Buy
141,320
+13,758
+11% +$97.5K ﹤0.01% 4340
2025
Q2 		$1.07M Sell
127,562
-7,392
-5% -$53.8K ﹤0.01% 4230
2025
Q1 		$856K Buy
134,954
+14,581
+12% +$126K ﹤0.01% 4234
2024
Q4 		$1.06M Buy
+120,373
New +$1.22M ﹤0.01% 4206
2022
Q4 		– Sell
-19,690
Closed -$362K – 5776
2022
Q3 		$362K Sell
19,690
-5,469
-22% -$148K ﹤0.01% 4818
2022
Q2 		$535K Buy
25,159
+2,480
+11% +$60.1K ﹤0.01% 4758
2022
Q1 		$704K Buy
22,679
+360
+2% +$13.2K ﹤0.01% 4782
2021
Q4 		$1.02M Buy
+22,319
New +$1.41M ﹤0.01% 4664

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

BlackRock's HELP Position: Q2 2026 in Review

BlackRock increased its Helus Pharma Inc. Common Stock (HELP) stake by 177% in Q2 2026, buying an estimated $258K and bringing the position to 80,719 shares worth $534K. The position accounts for ﹤0.01% of the portfolio, ranked #4563.

BlackRock first reported a position in HELP in Q4 2021 and has held it in 11 quarters since. The position peaked at $1.07M in Q2 2025. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • BlackRock held 80,719 shares of Helus Pharma Inc. Common Stock worth $534K as of Q2 2026.
  • BlackRock bought 51,593 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $258K.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4563 holding.
  • BlackRock first reported a position in Helus Pharma Inc. Common Stock in Q4 2021 and has held it in 11 quarters since.
  • BlackRock's Helus Pharma Inc. Common Stock position peaked at $1.07M in Q2 2025.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.